You just read:

VIDEO from Roche Pharmaceuticals Available on thenewsmarket.com: Study Showed Rituxan/MabThera for Initial Use Followed by Continued Use Delayed Need for Additional Therapy in People with Asymptomatic Follicular Lymphoma

News provided by

thenewsmarket.com

Dec 05, 2010, 10:31 ET